. Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease. Brain Res. 2017 Nov 8; PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.